Clinical features of BCG lymphadenitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, H.J. | - |
dc.contributor.author | Song, D.I. | - |
dc.contributor.author | Kim, Y.K. | - |
dc.contributor.author | Jang, G.Y. | - |
dc.contributor.author | Choi, B.M. | - |
dc.contributor.author | Lee, J.H. | - |
dc.date.accessioned | 2021-09-09T00:16:18Z | - |
dc.date.available | 2021-09-09T00:16:18Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1226-3923 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/121865 | - |
dc.description.abstract | Purpose: This study was performed to determine the clinical course of BCG lymphadenitis. Methods: Between May 2005 and April 2009, the medical records of 33 patients with BCG lymphadenitis were retrospectively reviewed. If needed, needle aspiration was recommended without surgical resection or antituberculous medication. Results: Of the 33 patients who were identified, 21 were males and 12 were females. Among the 33 patients, 32 were full-term babies. The mean age was 6 months (range, 2-35 months) and the most prevalent site of the lesion was the left axilla. BCG lymphadenitis was observed 1-34 months after BCG vaccination, mostly 1-6 months after vaccination. The size of the enlargement was generally 1-3 cm. The strains were identified as French (n=14), Danish (n=7), and Tokyo (n= 12). BCG lymphadenitis regressed spontaneously in 19 patients. After 1-5 needle aspirations, 14 patients recovered completely. Complete regression of lymphadenitis was recorded over an average period of 4 months. Conclusion: Clinicians need to be aware of the clinical features of BCG lymphadenitis. For management of BCG lymphadenitis, regular follow-up with observation should be the mainstay. Needle aspiration is a safe and easy treatment for suppurative BCG lymphadenitis. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | The Korean Society of Pediatric Infectious Diseases | - |
dc.title | Clinical features of BCG lymphadenitis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, B.M. | - |
dc.contributor.affiliatedAuthor | Lee, J.H. | - |
dc.identifier.doi | 10.14776/kjpid.2009.16.1.80 | - |
dc.identifier.scopusid | 2-s2.0-84869110943 | - |
dc.identifier.bibliographicCitation | Korean Journal of Pediatric Infectious Diseases, v.16, no.1, pp.80 - 86 | - |
dc.relation.isPartOf | Korean Journal of Pediatric Infectious Diseases | - |
dc.citation.title | Korean Journal of Pediatric Infectious Diseases | - |
dc.citation.volume | 16 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 80 | - |
dc.citation.endPage | 86 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001414166 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | BCG vaccine | - |
dc.subject.keywordAuthor | Lymphadenitis | - |
dc.subject.keywordAuthor | Management | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.